Rhythm Biosciences Ltd
ASX:RHY

Watchlist Manager
Rhythm Biosciences Ltd Logo
Rhythm Biosciences Ltd
ASX:RHY
Watchlist
Price: 0.185 AUD 2.78% Market Closed
Market Cap: AU$60.5m

Rhythm Biosciences Ltd
Investor Relations

Rhythm Biosciences Ltd. engages in the research, development, and commercialization of medical diagnostics technologies. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-12-07. The firm is engaged in developing and commercializing Australian medical diagnostics technology for sale in domestic and international markets. The Company’s development stage product, ColoSTAT focuses to provide early detection test for colorectal cancer. The Company’s ColoSTAT blood test is used to detect colorectal cancer at all stages, including the early ones. The firm's subsidiary includes Vision Tech Bio Pty Ltd.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Dr. David Atkins M.B.A., Ph.D.
CEO, MD & Director
No Bio Available
Mr. Guy Carisbrooke
Financial Controller
No Bio Available
Ms. Andrea Steele LLB B Com LLM
General Counsel & Joint Company Secretary
No Bio Available
Mr. James Stephen Barrie CPA
Joint Company Secretary
No Bio Available

Contacts

Address
VICTORIA
Melbourne
Level 17, 500 Collins Street
Contacts
+61396140600.0
www.rhythmbio.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett